ClinicalTrials.gg
RecruitingNCT06864715LIVE-WELUpdated Apr 28, 2026

Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors

An interventional study of Tele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S) and Treatment as Usual in Post-stroke Depression and Subthreshold Depression, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Depression by The University of Texas Health Science Center, Houston — 4 open to participants now, 6 under way, none of them phase 3. Depression · The University of Texas Health Science Center, Houston.

Planned enrollment
2nd of 15
350 · median 29
Started
2026
with 2 others
No phase
14 of 16
4 open now
Registered
14th of 16
by date

Among the 16 studies in Depression by The University of Texas Health Science Center, Houston, this one is the 2nd largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2026, is one of 14 with no phase, and was the 14th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

4 of the 16 studies in Depression by The University of Texas Health Science Center, Houston are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 55 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Depression by The University of Texas Health Science Center, Houston, or all of them as a file.
02

Study summary

The overall objective of the project is to determine the effectiveness of tele-delivered behavioral activation (BA) by trained lay counselors (Tele-BA-S) to prevent Post-stroke depression (PSD) in low-income, older stroke survivors with subthreshold depression (SD).

03

Conditions studied

  • Post-stroke Depression
  • Subthreshold Depression
04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Enrollment within 3-months +2 weeks of a first-time ischemic or hemorrhagic stroke
  • 24-item HDRS score \< 15 indicating subthreshold depression defined as the absence of depressive symptoms or presence of mild symptoms of depression
  • Single person income less than or equal to $45,000
  • Residing in a community residence
  • Ability to speak and read in English or Spanish
  • Mini- score > or equal to 11

Exclusion criteria

Exclusion Criteria:

  • Stroke event unrelated to vascular risk factors (e.g., drug use) or
  • 24-item HDRS score > or equal to 15 indicating moderate to severe depression
  • Actively participating in psychotherapy
  • high suicide risk or severe psychiatric illness (e.g., bipolar disorder and active psychosis) and/or actively taking antipsychotics
  • Diagnosed dementia and/or currently taking cognitive enhancers, amyloid-targeting medications, or orexin receptor antagonists
  • Patient Health Questionnaire 9 score > or equal to 10 and/or answers positive to Q9
  • Diagnosed aphasia and/or severe cognitive impairments
  • high-risk alcohol or drug misuse
  • receiving medications for mood disorders and a change in dose or type within the last 4 weeks
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    Tele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S)

    Behavioral: Tele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S)

  • Active comparator
    Treatment as Usual

    Behavioral: Treatment as Usual

Interventions

  • BehavioralTele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S)

    The Tele-BA-S intervention will comprise 5 weekly video-conferenced BA sessions delivered by trained lay counselors, homework, and 2 monthly follow-up booster calls. Participants will receive the standard hospital discharge post-stroke educational packet and a scheduled follow-up appointment with a stroke practitioner to evaluate patients at 7-14 days and 3 months ±14 days, according to current standard of care. They will be seen over video or in-person, according to their preference and capabilities.

  • BehavioralTreatment as Usual

    Participants will receive the standard hospital discharge post-stroke educational packet and a scheduled follow-up appointment with a stroke practitioner to evaluate patients at 7-14 days and 3 months ±14 days, according to current standard of care. They will be seen over video or in-person, according to their preference and capabilities.

06

What researchers measure

Primary outcomes

  1. Post-Stroke Depression as Assessed by Score on the Hamilton Depression Rating Scale (HDRS) 24-item

    Total score on the 24-item HDRS ranges from 0 to 52, with a higher score indicating greater depression.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  2. Subthreshold Depression (Depressive Symptoms) as Assessed by the Patient Health Questionnaire (PHQ-9)

    Total score on the PHQ-9 ranges from 0 to 27, with a higher score indicating greater depression.

    Time frame: baseline, 1 month, 2 months, 4 months, 6 months, 9 months

Secondary outcomes

  1. Anxiety as Assessed by the Generalized Anxiety Disorder- 7 Item (GAD-7)

    Total score on the GAD-7 ranges from 0 to 15, with a higher score indicating greater anxiety.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  2. Change in Emotional Distress as Assessed by the Ryff Psychological Well-being Scale (PWB)

    Emotional distress will be evaluated using the Ryff Psychological Well-Being Scale (PWB), a validated self-report instrument measuring psychological well-being across six domains: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Participants rate agreement with statements on a 6-point Likert scale ranging from strongly disagree to strongly agree. Scores are calculated for each domain and/or as a total composite score, with higher scores indicating greater psychological well-being (lower emotional distress).

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  3. Quality of Life (QOL) as Assessed by the Short Form Stroke Specific Quality of Life Scale (SS-QOL)

    Total score on the SS-QOL ranges from 12-60, with a higher score indicating better functioning.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  4. Number of Self-Reported Emergency Room Visits Over the Course of the Study

    calculated number of emergency room visits over course of study

    Time frame: From baseline to 9 months

  5. Number of Hospitalizations Over the Course of the Study

    calculated number of hospitalizations over course of study

    Time frame: From baseline to 9 months

  6. Disability as Assessed by the Modified Rankin Scale (mRS)

    Total score on the mRS ranges from 0-6, with a higher score indicating greater disability.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  7. Medication Adherence Report Scale-5

    Total score ranges from 5 to 25, with higher scores indicating higher self-reported adherence.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  8. Rehabilitation Adherence Inventory

    Greater total scores indicate greater adherence.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  9. Barthel Index

    Total scores range from 0 to 100, with lower scores indicating higher dependency.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Beauchamp JES, Savitz SI, Sharrief A, Reininger BM, Acierno R, Suchting R, Burnett J, Rosales L, Albaqali JA, Rajan R, Choi NG. Behavioural activation for the prevention of poststroke depression in low-income older stroke survivors (LIVE WEL): protocol for a randomised controlled trial. BMJ Open. 2026 Jun 7;16(6):e120452. doi: 10.1136/bmjopen-2026-120452. PubMed 42252135 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Nov 2029, 42 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 42 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2025
First posted
Mar 7, 2025
StartActual
Apr 10, 2026
Primary completionEst.
Nov 1, 2029
CompletionEst.
Nov 1, 2029
Last update
Apr 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06864715
Responsible party
Jennifer Beauchamp (Associate Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Mar 7, 2025
Start date
Apr 10, 2026
Primary completion
Nov 1, 2029 (estimated)
Completion
Nov 1, 2029 (estimated)
Last update
Apr 28, 2026

Study contacts

Jennifer Beauchamp, PhD, RN
Contact
Jennifer.e.Beauchamp@uth.tmc.edu
713-500-2114
Jennifer Beauchamp, PhD, RN
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion